Can YKL-40 be an Inflammatory Biomarker in Vitamin D Deficiency?

International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition
Ummugulsum CanBahauddin Taha Hidayetoglu

Abstract

Vitamin D deficiency is associated with several non-homeostatic conditions and/or diseases like inflammation, atherosclerosis, cardiovascular disease and mortality. YKL-40 is a glycoprotein, secreted by macrophages, neutrophils and different cell types and it is also associated with inflammation and pathological tissue remodeling. In this study, we aimed to evaluate relationship between the proinflammatory biomarkers YKL-40 and hs-CRP levels and vitamin D deficiency. Our study group includes 45 subjects with vitamin D deficiency (Group 1) (20 M, 25 F; mean age 37.72 ± 7.70 years) and 40 age and sex-matched healthy subjects with normal serum levels of vitamin D (Group 2) (19 M, 21 F; mean age 39.26 ± 7.41 years). Plasma 25 (OH) vitamin D levels were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Plasma YKL-40 analysis was performed by ELISA. Serum hs-CRP levels were measured by nephelometric method. Plasma vitamin D levels below 20 ng/mL were accepted as vitamin D deficiency. Although we could not find any significant differences by means of serum hs-CRP levels between Group 1 and Group 2 (2.21 (0.27-11.70); 1.79 (0.16-9.85) mg/L, p = 0.247), plasma YKL-40 levels were significantly higher in group ...Continue Reading

References

Jan 1, 1993·Scandinavian Journal of Rheumatology·H KrögerE M Alhava
Sep 7, 2006·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C N Rathcke, H Vestergaard
Mar 9, 2007·The American Journal of Clinical Nutrition·Carlos A CamargoMatthew W Gillman
Jul 20, 2007·The New England Journal of Medicine·Michael F Holick
Aug 30, 2007·Journal of Gastroenterology and Hepatology·Yusuf ErzinAykut Ferhat Celik
Nov 17, 2007·American Journal of Epidemiology·M Kyla SheaEmelia J Benjamin
Mar 20, 2009·International Archives of Allergy and Immunology·Lim ShuhuiW S Fred Wong
Apr 30, 2010·Current Opinion in Pharmacology·Femke BaekeChantal Mathieu
Jun 19, 2010·American Journal of Respiratory and Critical Care Medicine·Myung Hyun SohnJack A Elias
Jun 23, 2010·The American Journal of Pathology·Shaoping WuJun Sun
Aug 28, 2010·Current Drug Targets·LaPrincess C BrewerJared P Reis
Nov 12, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Xavier GuillotMarie-Christophe Boissier
Mar 23, 2011·Vitamins and Hormones·Wim JanssensMarc Decramer
May 1, 2012·Current Osteoporosis Reports·Daniel D Bikle
Jun 21, 2013·Inflammation & Allergy Drug Targets·Dhruv ParekhAlice M Turner
Jun 25, 2013·Pharmacology & Therapeutics·Audrey H PoonQutayba Hamid
Feb 24, 2015·The Journal of Clinical Endocrinology and Metabolism·Mercedes Clemente-PostigoManuel Macías-González
Jan 1, 2014·International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition·Elena Rodríguez-RodríguezRosa M Ortega
Oct 31, 2015·PloS One·Ewa Żurawska-PłaksejAgnieszka Piwowar
Mar 10, 2016·The American Journal of Gastroenterology·Toufic A KabbaniDavid G Binion

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
bronchoalveolar
biopsies

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Clinica Chimica Acta; International Journal of Clinical Chemistry
Stig E BojesenBørge G Nordestgaard
European Review for Medical and Pharmacological Sciences
F N Turhan CaglarO Karakaya
Scandinavian Journal of Clinical and Laboratory Investigation
Anders Bruun MathiasenJ Kastrup
© 2022 Meta ULC. All rights reserved